Two-year outcomes after selective early treatment of patent ductus arteriosus with ibuprofen in preterm babies: follow-up of Baby-OSCAR–a randomised controlled trialResearch in context
Summary: Background: Children born extremely preterm are at increased risk of developmental problems and respiratory morbidity due to patent ductus arteriosus (PDA). The objective of this study was to evaluate whether early treatment of a PDA ≥1.5 mm with ibuprofen improved neurodevelopmental and r...
Saved in:
| Main Authors: | Samir Gupta, Heather O'Connor, Edmund Juszczak, Nimish V. Subhedar, Ursula Bowler, Charlotte Clarke, David Field, Elizabeth Hutchison, Wilf Kelsall, Justine Pepperell, Tracy Roberts, Sunil Sinha, Kayleigh Stanbury, Jonathan Wyllie, Pollyanna Hardy, Samantha Johnson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | EClinicalMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537025003566 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective factors against preterm infants to develop significant patent ductus arteriosus
by: Hsiao-Wen Huang, et al.
Published: (2021-07-01) -
Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety
by: Haşim Olgun, et al.
Published: (2017-02-01) -
Comparison of the Effectiveness of Paracetamol and Ibuprofen in the Management of Patent Ductus Arteriosus in Preterm Neonates: A Randomized Controlled Trial
by: S. Mohsin Ali Shah, et al.
Published: (2025-01-01) -
Predicting Risk for Patent Ductus Arteriosus in the Neonate: A Machine Learning Analysis
by: Ana Maria Cristina Jura, et al.
Published: (2025-03-01) -
Transcatheter closure of patent ductus arteriosus in infants weighing less than 6 kilograms – a two-center experience. Technical considerations
by: Michał Gałeczka, et al.
Published: (2025-06-01)